Linfoma difuso de células grandes B rectal en un paciente con colitis ulcerosa
暂无分享,去创建一个
David Ladrón de Guevara | María Teresa Vial | Udo Kronberg | Daniela Simian | Lilian Flores | R. Quera | M. García-Rodríguez | D. Simian
[1] Sang‐wook Lee,et al. Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients , 2017, Blood research.
[2] J. Gisbert,et al. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry , 2017, The American Journal of Gastroenterology.
[3] Z. Ge,et al. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma , 2016, World Journal of Surgical Oncology.
[4] D. Winter,et al. Primary colorectal lymphoma - A single centre experience. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[5] K. Van Steen,et al. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodies , 2014, Pharmacoepidemiology and drug safety.
[6] W. Sandborn,et al. Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry , 2014, The American Journal of Gastroenterology.
[7] L. Bazzano,et al. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. , 2013, Gastroenterology.
[8] P. Lakatos,et al. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. , 2013, Journal of Crohn's & colitis.
[9] A. Ananthakrishnan,et al. Effects of cancer treatment on inflammatory bowel disease remission and reactivation. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] B. Ramakrishna,et al. Gastrointestinal lymphomas: pattern of distribution and histological subtypes: 10 years experience in a tertiary centre in South India. , 2011, Indian journal of pathology & microbiology.
[11] Guangyao Wu,et al. Primary gastrointestinal lymphoma. , 2011, World journal of gastroenterology.
[12] Jinny Park,et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. , 2011, Blood.
[13] J. Stockman. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2011 .
[14] J. West,et al. Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study , 2010, The American Journal of Gastroenterology.
[15] B. Sands,et al. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] M. Czuczman,et al. The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum. , 2007, American journal of surgery.
[17] J. Askling,et al. Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics , 2006, Cancer Epidemiology Biomarkers & Prevention.
[18] M. Wong,et al. Primary colorectal lymphomas , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[19] A. Iliadou,et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[20] Z. Barta,et al. Pulse cyclophosphamide therapy for inflammatory bowel disease. , 2006, World journal of gastroenterology.
[21] F. Quayle,et al. Colorectal lymphoma. , 2006, Clinics in colon and rectal surgery.
[22] J. Kim,et al. Primary Colon Lymphoma in Korea: A KASID (Korean Association for the Study of Intestinal Diseases) Study , 2005, Digestive Diseases and Sciences.
[23] C. Brensinger,et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.
[24] Takayuki Takahashi,et al. Association of intestinal malignant lymphoma and ulcerative colitis. , 2003, Internal medicine.
[25] R. Cartwright,et al. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. , 2002, The hematology journal : the official journal of the European Haematology Association.
[26] H. Lee,et al. Primary colorectal lymphoma: spectrum of imaging findings with pathologic correlation , 2002, European Radiology.
[27] A. Zinsmeister,et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. , 2002, Gastroenterology.
[28] N. Willich,et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] C. Y. Wang,et al. Colonoscopic manifestations of primary colorectal lymphoma. , 2001, Endoscopy.
[30] C. Copie-Bergman,et al. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. , 1997, The Journal of pathology.
[31] M. Larson,et al. Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy. , 1994, Journal of clinical gastroenterology.
[32] G. Dodd,et al. Lymphoma of the hollow abdominal viscera. , 1990, Radiologic clinics of North America.
[33] N. Shepherd,et al. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations , 1988, Histopathology.
[34] J. Berg,et al. Occurrence and prognosis of extranodal lymphomas , 1972, Cancer.